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Edited by Karin Musier-ForsythThe cariogenic pathogen Streptococcus mutans contains two
CRISPR systems (type I-C and type II-A) with the Cas5c pro-
tein (SmuCas5c) involved in processing of long CRISPR RNA
transcripts (pre-crRNA) containing repeats and spacers to
mature crRNA guides. In this study, we determined the crystal
structure of SmuCas5c at a resolution of 1.72 Å, which revealed
the presence of an N-terminal modified RNA recognition motif
and a C-terminal twisted β-sheet domain with four bound
sulphate molecules. Analysis of surface charge and residue
conservation of the SmuCas5c structure suggested the location
of an RNA-binding site in a shallow groove formed by the RNA
recognition motif domain with several conserved positively
charged residues (Arg39, Lys52, Arg109, Arg127, and Arg134).
Purified SmuCas5c exhibited metal-independent ribonuclease
activity against single-stranded pre-CRISPR RNAs containing a
stem–loop structure with a seven-nucleotide stem and a pen-
taloop. We found SmuCas5c cleaves substrate RNA within the
repeat sequence at a single cleavage site located at the 30-base
of the stem but shows significant tolerance to substrate
sequence variations downstream of the cleavage site. Structure-
based mutational analysis revealed that the conserved residues
Tyr50, Lys120, and His121 comprise the SmuCas5c catalytic
residues. In addition, site-directed mutagenesis of positively
charged residues Lys52, Arg109, and Arg134 located near the
catalytic triad had strong negative effects on the RNase activity
of this protein, suggesting that these residues are involved in
RNA binding. Taken together, our results reveal functional
diversity of Cas5c ribonucleases and provide further insight
into the molecular mechanisms of substrate selectivity and
activity of these enzymes.
The complex process of the adaptive immunity imple-
mented by the CRISPR and their associated (Cas) genes has
been harnessed to revolutionize the fields of molecular biology,* For correspondence: Alexander F. Yakunin, a.iakounine@utoronto.ca.
© 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).biotechnology, and medicine (1–4). Three main stages of
CRISPR immunity include adaptation, RNA maturation, and
interference (5, 6). During the initial adaptation stage, new
spacer sequences are excised from foreign nucleic acids and
inserted into the host CRISPR array, separated by the “repeat”
sequences of that locus. In the second stage, the long RNA
transcript of the CRISPR locus (pre-crRNA) is specifically
cleaved generating individual crRNAs consisting of a single
spacer and flanking repeat sequences. These crRNAs bind to
Cas proteins to form effector complexes that degrade the
corresponding target sequences in the final stage of CRISPR
immunity (interference) (7, 8). Although this is the general
process of CRISPR immunity, the specific way in which it is
achieved varies greatly among different types of CRISPR sys-
tems (9).
All CRISPR–Cas systems have been classified into two
classes (1 and 2), six types (class 1: types I, III, and IV; class 2:
types II, V, and VI), and further into 33 subtypes based on
repeat sequences and cas operon composition (10–13). The
processing of the pre-crRNA in the second step of CRISPR
immunity involves more diverse families of proteins (14–19).
In type II systems, an endogenous RNase III is responsible for
the cleavage of the pre-crRNA/transactivating crRNA duplex,
whereas the pre-crRNA processing is mediated by a multi-
domain Cas protein in types V (Cas12) and VI (Cas13)
(13, 14, 19, 20). In type III systems (A and B), Cas6 performs
the crRNA maturation step by recognizing nonpalindromic
ssRNA and cutting the pre-crRNA (21–23). This generates
products 35 to 53 nt in length that are further processed into
an active crRNA and used as part of a larger complex, which
does not include Cas6, to target dsDNA or ssRNA (7, 24, 25).
Likewise, most type I and IV systems use variants of the Cas6
protein for crRNA maturation. Types I-A and I-B have
repeat RNAs similar to that in type III systems and therefore
have similarly functioning Cas6a and Cas6b proteins
(18, 20, 26, 27). However, the repeats of types I-D, I-E, and I-F
form hairpin structures (27), and the Cas6 proteins thatJ. Biol. Chem. (2021) 297(5) 101251 1
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Structure and activity of the Cas5c ribonuclease SMU1763cleave the pre-crRNA at the 30-base of the stem–loop (Cas6d,
Cas6e, and Cas6f) remain associated with the crRNA as they
form the effector complexes. Structures of type I-E and type
I-F crRNA-guided complexes demonstrated that these
crRNAs are not processed further (9, 28–31).
Type I-C (previously Dvulg) is the only CRISPR subtype
that employs a Cas5 variant, Cas5c (originally known as
Cas5d), to process pre-crRNA (10). This protein family is
unique as it performs the roles of both Cas5 and Cas6 pro-
teins (18, 19, 22, 23). The repeat sequences in this subtype are
also predicted to form stable RNA hairpin structures, and the
biochemically and structurally characterized Cas5c proteins
from Bacillus halodurans (BhaCas5c), Streptococcus pyogenes
(SpyCas5c), Xanthomonas oryzae (XorCas5c), and Desulfo-
vibrio vulgaris (DvuCas5c) have been shown to cleave at the
30-base of the stem, with no further processing (32–35). Both
Cas5 and Cas6 proteins belong to the repeat-associated
mysterious protein (RAMP) superfamily containing one or
more RAMP domains with the RNA recognition motif (RRM)
fold (23). Cas6 proteins typically have two sequential RAMP
domains, whereas Cas5 proteins contain a single N-terminal
RAMP domain and a smaller C-terminal β-sheet domain with
the RAMP (RRM) domain responsible for substrate binding
and cleavage (in Cas5c) (32–34). RNA is cleaved through a
metal-independent acid–base hydrolysis, generating 50-OH
and 20,30-cyclic phosphate products (33). Based on sequence
analysis, two subgroups have been proposed within the Cas5c
family: the subgroup A (B. halodurans and S. pyogenes)
contains a C-terminal extension (30 residues), whereas the
subgroup B (X. oryzae) has an insertion (23 residues) be-
tween the β3 and β4 strands (34). The three biochemically
characterized Cas5c proteins were also found to exhibit
different functional properties. After RNA cleavage, the
BhaCas5c protein from B. halodurans has been shown to
assemble in a complex with the processed crRNA and the
Cas8c and Cas7 proteins to form an interference complex
(32). Furthermore, it has also been shown to bind and cleave
both single-stranded (ss) and double-stranded (ds) DNA (36).
Two other Cas5c proteins (SpyCas5c and XorCas5c) have
been shown to bind dsDNA nonspecifically but not cleave it
(34), underlining the diversity of the Cas5c protein family in
both structure and function.
Streptococcus mutans is a Gram-positive cariogenic bacte-
rium representing one of the major pathogens implicated in
human dental caries (37). The S. mutans UA159 genome re-
veals the presence of two CRISPR loci, CRISPR1 (type II-A)
and CRISPR2 (type I-C), with several spacers complementary
or highly similar to sequences in genomes of the phage M102
or other S. mutans strains (38–40) (Fig. 1A). The CRISPR2
cluster contains only one spacer and a degenerate second
repeat suggesting that it might be nonfunctional. However,
both CRISPR loci appear to be rigorously maintained in
S. mutans being present in most clinical and laboratory strains
(50–70%) (40). Recently, the presence of both CRISPR1 and
CRISPR2 loci in clinical isolates of S. mutans was also found to
be correlated with thicker biofilm production (40). In our
previous work, we demonstrated that the expression of both2 J. Biol. Chem. (2021) 297(5) 101251CRISPR systems in the S. mutans UA159 cells is differentially
modulated by the two-component signal transduction system
VicR/VicK (41). Moreover, further studies with cas deletion
mutants revealed that although deletions had no effect on
S. mutans acid production or tolerance, both CRISPR systems
appear to contribute to the stress response, whereas the
CRISPR1 system is also involved in resistance against
incoming plasmids containing target sequences (40, 41).
In the S. mutans genome, the Cas5c gene (SMU1763) is
associated with the CRISPR2 locus (type I-C), which is char-
acterized by the presence of a single spacer and several Cas
genes: cas1, cas2, cas3, cas4, cas5c, cas8c, and cas7 (Fig. 1A).
The purified SmuCas5c protein has been shown to be cata-
lytically active in vitro (41). However, the molecular mecha-
nisms of substrate specificity and pre-crRNA cleavage of
SmuCas5c remain unknown. In addition, significant variations
have been reported recently regarding the biochemical and
structural properties of BhaCas5c, SpyCas5c, and XorCas5c
(19, 32–34, 36). To provide further insights into catalytic ac-
tivities and functional diversity of the Cas5c family, we per-
formed detailed biochemical, structural, and mutational
studies on SmuCas5c. We have determined the crystal struc-
ture of SmuCas5c at a resolution of 1.7 Å and identified the
catalytic triad and other active site residues using site-directed
mutagenesis. Our work demonstrated that SmuCas5c is a
metal-independent RNase that specifically recognizes the pre-
crRNA stem–loop structure and cleaves it at the 30-stem base.
Compared with other Cas5c proteins (BhaCas5c), SmuCas5c
exhibits significant substrate plasticity and tolerates sequence
variations around the cleavage site.Results and discussion
Phylogenetic analysis of the Cas5c protein family
Most of the currently available Cas5c sequences (1635
genes; IPR010155; InterPro database) are present in bacterial
genomes (1614 proteins) with only 35 Cas5c genes found in
archaea and environmental metagenomes. Phylogenetic anal-
ysis of the Cas5c family revealed the presence of three major
monophyletic groups: I, II, and III (Fig. 2). The largest group I
contains Cas5c proteins from both Gram-negative and Gram-
positive bacteria including the biochemically characterized
DvuCas5c and XorCas5c proteins from Gram-negative bac-
teria (Fig. 2). The Cas5c groups II and III are phylogenetically
close to each other and contain sequences mostly from Gram-
positive bacteria (Firmicutes and Actinobacteria), including
BhaCas5c (group II), SpyCas5c (group III), and SmuCas5c
(group III) (Fig. 2). Based on sequence alignment, the group I
proteins include the Cas5c sequences with an insertion
(23 amino acids) in the RRM domain (DvuCas5c and
XorCas5c), whereas the members of groups II and III have a
C-terminal extension (26–29 amino acids) (BhaCas5c, Smu-
Cas5c, and SpyCas5c) (Fig. S1). A recent study on the cryo-EM
structure of the D. vulgaris cascade revealed that the RRM
domain insertion of DvuCas5c clamps around the Cas7.7
protein providing additional interactions within the cascade
complex (42). The phylogenetic Cas5c group I corresponds to
Figure 1. CRISPR–Cas systems of Streptococcus mutans UA159. A, organization of type II-A (CRISPR1) and type I-C (CRISPR2) loci along with their
associated Cas genes. The SmuCas5c gene is highlighted in orange. B, secondary structure of CRISPR1 repeat (R1), CRISPR2 repeat (R2), and their com-
plimentary strand RNAs (R1c and R2c, respectively). C, sequences of the crRNA repeats from S. mutans, Bacillus halodurans, Streptococcus pyogenes, and
Xanthomonas oryzae. Sequence variations between S. mutans and B. halodurans repeats are shown in red and blue, respectively. D, sequence and secondary
structure of the CRISPR2 locus as seen in S. mutans GS-5. crRNA, CRISPR-RNA.
Structure and activity of the Cas5c ribonuclease SMU1763the previously proposed subgroup B (originally, Cas5d-B),
whereas the groups II and III (SmuCas5c) are related to sub-
group A (originally, Cas5d-A) (34).Crystal structure of SmuCas5c reveals a modified RRM fold
Purified SmuCas5c was crystallized using the sitting-drop
vapor diffusion method, and its structure was determined at
a resolution of 1.72 Å using the selenomethionine (SeMet)-
substituted protein and single-wavelength anomalous disper-
sion method (Table S1). The protomer structure revealed the
presence of two domains, an N-terminal modified RRM
domain (also known as the ferredoxin fold, Met1–Pro160) and
a C-terminal twisted β-sheet domain (Tyr162–Thr214)
(Figs. 3A and S2). RRM domains contain approximately 90
residues folded into an αβ sandwich structure with aβ1α1β2β3α2β4 topology (43). The canonical RRM fold is
composed of one four-stranded antiparallel β-sheet flanked on
one side by two α helices (α1 and α2). Cas6 proteins typically
have two sequential RRM domains, whereas Cas5c contains an
N-terminal RRM domain and a C-terminal domain with a
three-stranded antiparallel β-sheet (23). Similar to crystal
structures of BhaCas5c, SpyCas5c, and XorCas5c (32, 34), the
topology of the SmuCas5c RRM domain deviates from the
canonical βαββαβ fold and contains additional β-strands
(within the twisted antiparallel β-sheet) (Figs. 3 and S2). The
SmuCas5c RRM domain has the β1α1β2β3β4α2α3β5β6 fold with
the unresolved residues Leu78–Ser87 (Figs. 3 and S2). The α1,
α2, and α3 helices of SmuCas5c are located on the concave
side of the central β-sheet, whereas α4 is positioned on the
other (convex) side (Fig. 3). A similar helix (labeled as α3) was
also observed in the crystal structure of SpyCas5c (ProteinJ. Biol. Chem. (2021) 297(5) 101251 3
Figure 2. Phylogenetic analysis of Cas5c proteins. Unrooted phyloge-
netic tree of Cas5c proteins (IPR010155) showing the presence of three
major monophyletic groups: I (previous subgroup B), II (previous subgroup
A), and III (previous subgroup A). About 1548 Cas5c sequences were aligned
using MAFFT online, version 7, and the tree was built using Geneious,
version 8.1.9, with 60% threshold. The red circles indicate the structurally
characterized Cas5c proteins: SmuCas5c (subgroup A) from Streptococcus
mutans, XorCas5c (subgroup B) from Xanthomonas oryzae, BhaCas5c
(subgroup A) from Bacillus halodurans, and SpyCas5c (subgroup A) from
Streptococcus pyogenes.
Structure and activity of the Cas5c ribonuclease SMU1763Data Bank [PDB] code: 3VZH) but was missing in other Cas5c
structures (BhaCas5c, DvuCas5c, and XorCas5c). The C-ter-
minal domain of SmuCas5c (Asn164–Gly249) includes the
twisted antiparallel β-sheet (β7, β8, β9, and β10), α5 helix
(Thr167–Lys202), and C-terminal tail (Leu215–Gly249),
which was disordered in the SmuCas5c crystal structure
(Figs. 3 and S1).
Size-exclusion chromatography of purified SmuCas5c sug-
gested that this protein exists as a dimer in solution (observed
mass of 61.2 kDa and predicted subunit mass of 28.7 kDa)
(Fig. S3). This is consistent with the prediction of a dimeric
biological unit using the PDBePISA tool (44) formed mainly by
interactions between the N-terminal strands (Asn2–Arg5) and
β4–α2 loops of two protomers with buried surface area of
950 Å2 (compared with 2300 Å2 for the DvuCas5c–Cas7
interface area in the D. vulgaris cascade complex) (Fig. 3B)
(42). The PDBePISA analysis also predicted a dimeric state for
BhaCas5c, which was verified using size-exclusion chroma-
tography using the purified BhaCas5c. As shown in Fig. S3, the
major peak appears to represent a dimer (observed mass
50.5 kDa and predicted subunit mass of 26.9 kDa). The pre-
vious structural study of BhaCas5c also revealed the presence
of two protein molecules in the asymmetric unit, but the
protein behaved as a monomer based on size-exclusion
chromatography and dynamic light scattering (32). Several4 J. Biol. Chem. (2021) 297(5) 101251Cas6 proteins from the types I-A and I-B CRISPR systems have
also been reported to form dimers (22).
A Dali search (45) for structurally homologous proteins in
the PDB database revealed several similar structures of char-
acterized and uncharacterized Cas5c proteins from different
bacteria with SpyCas5c from S. pyogenes as the top structural
homologue (PDB code: 3VZH; Z-score: 31.5; rmsd: 1.4 Å; and
80% sequence identity). The other three homologous Cas5c
structures include BhaCas5c from B. halodurans (PDB code:
4F3M; Z-score: 26.0; rmsd: 1.9 Å; and 46% sequence identity),
XorCas5c from X. oryzae (PDB code: 3VZI; Z-score: 22.9;
rmsd: 2.5 Å; and 26% sequence identity), and MsuCas5c
(MS0988) from Mannheimia succiniciproducens (PDB code:
3KG4; Z-score: 21.6; rmsd: 2.1 Å; and 27% sequence identity).
Surface charge analysis of the SmuCas5c structure revealed
that positively charged residues dominate in a shallow groove
formed by the RRM domain, which is likely to represent the
RNA-binding site (Fig. 4). The positively charged area extends
into the dimer interface, which represents a twofold symmetry
structure with the two positively charged grooves exposed on
one dimer side (Fig. 4G). Surface sequence conservation
analysis of the SmuCas5c dimer using the ConSurf web server
(46) demonstrated strong conservation of positively charged
residues located in both shallow grooves (e.g., Lys52, Arg134,
Lys120, Arg142) suggesting functional importance of these
residues for RNA binding (Fig. 4H).Sequence analysis of S. mutans crRNA repeats
As shown in Figure 1A, the S. mutans CRISPR1 cluster (type
II-A) contains six spacers (30 bp each) separated and flanked
by seven 36 bp repeats. The CRISPR2 locus (type I-C) has just
one spacer (34 bp) matching (100% identity) a sequence in the
S. mutans LJ23 genome and flanked by two repeats (32 bp),
which show no sequence similarity to the CRISPR1 repeats.
Analysis of potential secondary structures of the S. mutans
CRISPR repeats (both coding and complementary strands)
using the Mfold server (47) suggested the presence of a hairpin
(stem–loop) structure with a long 30-tail in the CRISPR2
repeat (type I-C) and a noncanonical long (13 nt) stem and
10 nt loop structure with neither 50-tail nor 30-tail in the
CRISPR1 repeats (Fig. 1B). This analysis predicted the for-
mation of hairpins with different stem lengths (13 and 8 nt) in
both CRISPR1 crRNAs, whereas both CRISPR2 repeats were
predicted to form similar stem–loop structures with a 7-nt
stem and 5-nt loop flanked by the 2-nt and 11-nt overhangs
(Fig. 1B).
Interestingly, the overall structure and lengths of the stem
(7-nt) and overhangs (2-nt and 11-nt) of the predicted crRNA
repeat structures are identical for the crRNA repeats from
S. pyogenes, B. halodurans, X. oryzae, and S. mutans (R2 from
CRISPR2) (Fig. 1B). The four crRNA repeats (B. halodurans,
X. oryzae, S. pyogenes, and S. mutans) also share high sequence
similarity with just 2 to 4 different nucleotides (88–94%
identity) and identical 50 (2 nt) and almost identical 30 (11 nt)
overhangs (Fig. 1C). In contrast, the corresponding Cas5c
Figure 3. Crystal structure of SmuCas5c. A–D, overall fold of the SmuCas5c protomer: four views related by a 90 rotation. The protein RRM domain is
colored light orange, whereas the C-terminal twisted β-sheet domain is represented in a lime green color. E, SmuCas5c dimer (shown in the orientation
related to those in Fig. 4, G and H). The protein subunits are shown as ribbon diagrams with secondary structure elements labeled. RRM, RNA recognition
motif.
Structure and activity of the Cas5c ribonuclease SMU1763proteins have low overall sequence similarity (26–80%
sequence identity) (Fig. S1).Nuclease activity of purified SmuCas5c
The hallmark of all Cas5c proteins biochemically charac-
terized to date is the specific cleavage of palindromic repeat
crRNA at the 30-base of the stem–loop region (22, 32, 34). In
addition, the repeat sequence must belong to the CRISPR lo-
cus associated with the Cas5c protein, making the ribonuclease
activity both sequence and structure dependent (32, 34). To
characterize specific RNase activity of SmuCas5c against
CRISPR-related RNA substrates, we designed four synthetic
RNA substrates (R1, R1c, R2, and R2c) using the repeatsequences of the two S. mutans CRISPR loci, both coding (R1
and R2) and complementary strands (R1c and R2c) (Fig. 1B).
Nuclease assays with purified SmuCas5c using 50-[32P]-labeled
repeat crRNAs, as well as a scrambled RNA substrate (RC),
revealed the presence of endoribonuclease activity against the
CRISPR2 repeat RNA (R2), whereas the other four substrates
were not cleaved (Fig. 5A). Cleavage of the R2 substrate by
SmuCas5c produced a single [32P]-labeled product with the
length approximately 20 nt indicating that the cleavage site is
located close to the 30-side of the R2 stem–loop base. Endor-
ibonuclease activity of SmuCas5c was found to be metal in-
dependent with no inhibition by divalent metal ions or EDTA
except for Cu2+ (Fig. 5C). This is in line with a metal-
independent crRNA cleavage reported for the B. haloduransJ. Biol. Chem. (2021) 297(5) 101251 5
Figure 4. Crystal structure of SmuCas5c: surface analysis of the dimer. A, C, E, and G, distribution of surface potential shown in four orientations with a
blue (positively charged) to red (negatively charged) gradient. B, D, F, and H, conservation of surface residues shown in four orientations with a magenta
(conserved) to cyan (variable) gradient. The scale bars show coloring schemes of the surface-exposed residues. The positions of catalytic residues are
indicated by arrows. Dimer orientations shown in panels G and H are related to that shown in Figure 3E.
Structure and activity of the Cas5c ribonuclease SMU1763Cas5c (32). This activity was also maximal at pH 7 to 10 and
was insensitive to KCl concentrations up to 200 mM (Fig. S3,
G and H). Thus, our results with SmuCas5c confirmed a strong
preference of Cas5c proteins for the CRISPR repeat RNA as
well as the metal-independent cleavage of RNA at neutral–
alkaline pH and the absence of inhibition by KCl. Likewise,
while it is possible for Cas proteins to be shared between
CRISPR loci within an organism, it is uncommon for the
RNA-processing enzymes to mature different kinds of pre-
crRNA (19).
Although Cas5c proteins have been shown to function in
crRNA processing as structure-specific and sequence-
specific RNases, the three biochemically characterized
Cas5c enzymes also exhibited DNA binding (SpyCas5c and
XorCas5c) or DNA cleavage (BhaCas5c) activities (34, 36).
Therefore, the purified SmuCas5c (Fig. S3A) was tested for
the presence of DNA binding and cleavage activities6 J. Biol. Chem. (2021) 297(5) 101251toward ssDNA and dsDNA. In accordance with our pre-
vious study (41), no nuclease or DNA-binding activities
were found using ssDNA (circular M13mp18 phage DNA;
DNA1) or dsDNA (circular pUC19 plasmid; DNA1/DNA2)
as substrates in the absence/presence of metal ions
(Fig. S3, B–E).SmuCas5c activity: Analysis of crRNA cleavage site and
products
Metal-independent RNases usually cleave the phospho-
diester bond of their RNA substrates with the formation of
20,30-cyclic phosphate and 50-OH groups (48). This was also
true for the biochemically characterized BhaCas5c from
B. halodurans (32). The crRNA cleavage products of Smu-
Cas5c were analyzed using T4 polynucleotide kinase (PNK) in
the reactions of direct phosphorylation of cleavage products at
A
C     214   428 C   214    428 C    214   428 C   214    428 C    214    428   nM SmuCas5c
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Figure 5. RNase activity of SmuCas5c against different RNA substrates. A, screening of purified SmuCas5c against five different RNA substrates.
50-[32P]-labeled repeat and complimentary repeat RNAs from CRISPR1 and CRISPR2 or scrambled RNA were incubated with 214 nM or 428 nM SmuCas5c at
37 C for 15 min. B, cleavage of R2 RNA in the presence of increasing amounts of SmuCas5c (21–856 nM; 15 min incubation at 37 C). C, effect of divalent
metal ions on R2 cleavage by 214 nM SmuCas5c (15 min incubation at 37 C). All gels were analyzed using denaturing PAGE alongside a DNA marker, and
blue arrows indicate the positions of uncleaved substrate bands.
Structure and activity of the Cas5c ribonuclease SMU1763the 50-end (requires a 50-OH end) and phosphate exchange at
the 50-end (requires a 50-phosphate end). These experiments
revealed high product labeling by PNK in the forward phos-
phorylation reaction (Fig. 6A) and no product labeling in the
phosphate exchange reaction (data not shown) suggesting the
formation of a 50-OH as one of the SmuCas5c products (and
supposedly 20,30-cyclic phosphates as the second product). The
formation of these product termini is consistent with a
cleavage mechanism based on the attack of the G21 20-hy-
droxyl group on the scissile phosphodiester. Similar RNA
cleavage product ends (50-OH and 20,30-cyclic phosphate) have
been reported for Cas5c proteins from Thermus thermophilus
and B. halodurans as well as for several Cas6 proteins
(19, 22, 32, 33, 49). To confirm the integrity of the dsRNA
region of the R2 stem structure, we used the monospecific
RNase T1, which is known to cleave after guanine in ssRNA
areas (50). The formation of reaction products with the lengths23, 24, and 28 nt and the absence of shorter reaction products
(4–21 nt) after incubation with RNase T1 suggested that the
stem structure of the R2 RNA remained intact during the
reaction (Fig. 6B).
The exact size of the 50-[32P]-labeled cleavage product of
the R2 substrate was determined using truncated versions of
the R2 substrate (20 and 21 nt long) containing either a 30-
OH or 30-phosphate as markers. As shown in Figure 6C,
these assays revealed that the length of the SmuCas5c
product of R2 cleavage is 21 nt and confirmed the formation
of a phosphorylated 30-end of the product. This suggests
that processing of pre-crRNA by SmuCas5c produces
mature crRNAs (65 nt) containing a single spacer (33 nt)
with the 50-handle (11 nt) and 30 stem–loop part (21 nt).
Purified SmuCas5c and BhaCas5c also produced identical
products (21 nt) during cleavage of the B. halodurans repeat
as substrate (Fig. S4). Thus, Cas5c proteins from differentJ. Biol. Chem. (2021) 297(5) 101251 7
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Figure 6. Product analysis of RNA cleavage by SmuCas5c. A, PNK catalyzed forward phosphorylation labeling of reaction products of the R2 RNA
cleavage by purified SmuCas5c. A schematic of major products is indicated on the side. B, cleavage of the R2 substrate by RNase T1 (Ambion) or SmuCas5c.
The sequence and predicted structure of R2 are shown with the 32P-label indicated with an asterisk. Green G letters in the substrate indicate potential
cleavage sites for RNase T1, whereas red G letters indicate nucleotides located within the stem structure (which are not supposed to be cleaved). Major
products formed by both enzymes are indicated with arrows. C, cleavage products of 50-[32P]-labeled R2 substrate by SmuCas5c or BhaCas5c (640 nM each)
alongside 20 and 21 nt R2 RNA markers containing either 30-OH or 30-phosphate ends (20 min at 37 C). D, cleavage of 50-[32P]-labeled repeat–spacer–repeat
RNA by SmuCas5c (214–856 nM) after 45 min at 37 C analyzed by denaturing gel electrophoresis alongside a 20 to 100 nt DNA marker (IDT). E, cleavage of
50-[32P]-labeled repeat–spacer–repeat RNA by SmuCas5c or BhaCas5c (856 nM each) analyzed by denaturing gel electrophoresis alongside a 20 to 100 nt
DNA marker, alkaline hydrolysis ladder of the R2 substrate, and a 21 nt R2 marker (30 min at 37 C). R2_SMU is the product of 640 nM SmuCas5c incubated
with 50-[32P]-labeled R2 substrate (20 min at 37 C). A schematic of full-size substrate and major products of estimated size is indicated. All gels were
analyzed using denaturing PAGE, and blue arrows indicate the positions of uncleaved substrate bands. PNK, polynucleotide kinase.
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Structure and activity of the Cas5c ribonuclease SMU1763phylogenetic groups exhibit high conservation of the
mechanisms of pre-crRNA cleavage with the cleavage site
located after the nucleotide-21 at the hairpin base.
Substrate specificity of SmuCas5c was further characterized
using a synthetic 50-[32P]-labeled RNA with the repeat–spacer–
repeat (R–S–R) sequence from the S. mutans GS-5 (type I-C)
locus with the R2 repeat (Fig. 1D). Given synthesis restrictions
and the fact that the 50-end of the repeat sequence was previ-
ously shown to be not critical for crRNA processing (32), the
first seven nucleotides of the repeat were omitted from the 50-
end of the substrate (Table S2). This RNA substrate contains
two potential cleavage sites for SmuCas5c, which is expected to
generate two 32P-labeled products (79 and 14 nt) given the
cleavage site location at the bottom of the stem loop. As ex-
pected, incubation of the R–S–RRNA substrate with SmuCas5c
produced two 50-labeled products with the long product around
79 nt and the short product less than 21 nt in length (Fig. 6, D
and E). The cleavage of the R–S–R construct by SmuCas5c
confirmed the site-specific mechanism of crRNA cleavage by
this enzyme. Although the first seven nucleotides of the 50-ter-
minal repeat were missing, the major cleavage product was still
around 79 nt in length, corresponding to a cleavage site of 1 bp
into the second repeat sequence. A smaller product that is less
than 20 nt in length (expected size of 14 nt) indicates that the
cleavage of the first repeat is not based on a rulermechanism but
rather on crRNA sequence and structure. Purified BhaCas5c
was found to generate the same products (79 and 14 nt) after
cleavage of the S. mutans R–S–R crRNA substrate (Fig. 6E).
Thus, the cleavage of the R–S–R construct further confirmed
the structure-specific and site-specific mechanism of pre-
crRNA cleavage by Cas5c proteins.
Previous studies with BhaCas5c revealed that the crRNA
recognition was focused mostly on the trinucleotide sequence
(U22–G23–G24) immediately downstream of the cleavage site
with crRNA processing inhibited by mutations near the
cleavage site (at the stem–loop base) and in the 30overhang but
not in the pentaloop (UUCAU) or 50-overhang (32). This is in
contrast to Cas6 proteins recognizing the crRNA stem–loop
part and upstream nucleotides (22). Given high similarity of
the S. mutans and B. halodurans repeat sequences and low
similarity between SmuCas5c and BhaCas5c (46% sequence
identity), we thought to compare the tolerance of these en-
zymes to sequence variations around the crRNA R2 cleavage
site. As shown in Figure 7, SmuCas5c and BhaCas5c showed
comparable cleavage activities with the wildtype S. mutans
crRNA substrate (R2). With mutated R2 substrates, SmuCas5c
showed slightly reduced cleavage of the U22G variant but
exhibited close to wildtype activities against the C20G, G21U,
and G23U substrates. In contrast, the activity of BhaCas5c
toward U22G was almost abolished (Fig. 7). These results
indicate that SmuCas5c exhibits a greater tolerance to sub-
strate sequence variations compared with BhaCas5c including
mutations located downstream of the cleavage site.
Crystal structures of Cas5c proteins revealed that the active
site of SmuCas5c includes His51, which is replaced by Trp47
in BhaCas5c, Trp51 in DvuCas5c, or Tyr46 in DvuCas5c
(Figs. 8A, S1, and S4). Most bacterial and archaeal Cas5csequences show the presence of Trp, Tyr, or Phe at this po-
sition, whereas His is present mainly in various Streptococcus
strains (Streptococcus anginosus, Streptococcus constellatus,
Streptococcus equi, Streptococcus gordonii, etc). As revealed by
the cryo-EM structure of the D. vulgaris cascade–crRNA
complex, the DvuCas5c Trp51 is involved in crRNA binding
with the side chain positioned between the first two bases (U1
and G2) of the crRNA 50-handle (42). In the SmuCas5c active
site, the smaller side chain of His51 can also interact with
crRNA bases, but it has different steric properties compared
with Trp regarding substrate coordination (Fig. S4D). There-
fore, His51 is one of the residues potentially contributing to a
higher substrate plasticity of SmuCas5c compared with Bha-
Cas5c. Other potential SmuCas5c residues include Arg39,
Gln43, Asp47, Glu122, and Lys131 (Figs. 8A and S1).Mutational studies of the SmuCas5c active site
The crystal structure of SmuCas5c revealed the presence of
three sulfate molecules (presumably from the crystallization
mother liquor) bound in the positively charged groove, which
likely mimics phosphate groups of RNA (Fig. 8A). The S1
sulfate is bound near the side chains of Arg127 (2.7 Å), Lys131
(4.3 Å), and Arg134 (3.2 Å), whereas S2 is coordinated by
Arg135 (2.7–3.1 Å), and S3 is close to Arg39 (2.6–2.8 Å) and
Tyr179 (2.6 Å) (Fig. 8A). The fourth sulfate molecule (S4) is
bound nonspecifically outside the predicted RNA-binding
groove close to Tyr163 (3.9 Å). The bound sulfate S1 is
located in proximity to the side chains of conserved SmuCas5c
residues Tyr50 (6.8 Å), Lys120, and His121, which are closely
clustered in the space (2.8–4.3 Å) (Fig. 8A).
Cas5c and Cas6 enzymes have been proposed to use a
general acid–base mechanism based on a catalytic triad of His,
Tyr, and Lys, which may function as a general base, a general
acid, and in intermediate stabilization, respectively (22, 23, 32,
49). Previous studies on DvuCas5c suggested that the catalytic
triad of this enzyme includes Tyr46, Lys116, and His117,
which are located close to the 30-end of crRNA in the
D. vulgaris cascade–crRNA complex (32, 42). Metal ion–
independent RNase activity and RNA cleavage products of
SmuCas5c also suggest that this enzyme cleaves crRNA sub-
strates using a general acid–base mechanism similar to that of
RNase A and RNA-splicing endonucleases (51, 52). To gain
further insight into the SmuCas5c mechanism, Tyr50, Lys120,
and His121 were mutated to Ala, and RNase activity of purified
mutant proteins was analyzed using the R2 RNA substrate. As
shown in Figure 8B (and Fig. S5), alanine replacement muta-
genesis produced catalytically inactive proteins suggesting that
the catalytic triad of SmuCas5c includes Tyr50 (located at the
end of α1), Lys120, and His121 (both are located at the
beginning of α3). The catalytic triad Lys120 is the only triad
residue that is invariant in Cas5c proteins, whereas the Tyr50
and His121 can be replaced by other amino acids (His, Phe,
Leu, and Tyr) (23, 33, 34). This is in line with the absence of
homologous residues in crystal structures of noncatalytic Cas5
proteins (e.g., Escherichia coli Cas5; PDB: 4QYZ). According to
the proposed mechanism for SmuCas5c, His121 (the generalJ. Biol. Chem. (2021) 297(5) 101251 9
Figure 7. Substrate specificity of SmuCas5c (SMU1763) and BhaCas5c (BH0337). A, substrate cleavage of 50-[32P]-labeled wildtype or modified R2 RNAs
under stringent conditions by 20 nM to 1.3 μM SmuCas5c or BhaCas5c enzymes at 37 C for 30 min. The cleavage site is indicated using a red arrow, with
cut-site proximal nucleotide modifications highlighted in yellow, and noncleavage site modifications made to maintain structure stability highlighted in
gray. The repeat sequences of Bacillus halodurans and Streptococcus mutans are shown in Figure 1C. B, quantification of RNA cleavage gels showing protein
amount versus percentage of substrate cleaved for each of the wildtype or modified R2 RNA substrates. The analysis is shown as a mean ± SD of the gels
from panel A and Figure 4C.
Structure and activity of the Cas5c ribonuclease SMU1763base) is expected to deprotonate the nucleophilic 20-oxygen of
crRNA ribose, whereas Tyr50 (the general acid) apparently
protonates the leaving 50-hydroxyl oxygen, and Lys120 stabi-
lizes the developing negative charge of the transition state
(15, 24, 32, 53).
Based on the surface sequence conservation and sequence
alignment (Figs. 4 and S1), the single RRM domain of Smu-
Cas5c accommodates a large number of conserved charged
and polar residues, which are presumably involved in crRNA
binding. This is consistent with a recent study on the cryo-EM
structure of the D. vulgaris type I-C cascade showing that
homologous residues of DvuCas5c interact with the crRNA
50-handle (nucleotides U1–G12) (42). Accordingly, R2 cleav-
age assays with SmuCas5c mutant proteins revealed greatly
reduced activity in K52A, T54A, R109A, R127A, and R134A
suggesting that these residues are involved in binding of the
crRNA 50-handle (Fig. 8B). Furthermore, the bound sulfate S3
likely indicates a potential binding site for the crRNA stem–
loop part, which is in line with reduced R2 cleavage activity
of Y179A (Fig. 8B). The E. coli cascade structure (30) revealed
a similar (hooked) conformation of the crRNA 50-handle
bound to Cas5e indicating that interactions with the crRNA10 J. Biol. Chem. (2021) 297(5) 10125150-handle are critical for the assembly of cascade complexes. In
contrast, Cas6e recognizes the crRNA substrate mainly within
the stem–loop part and remains tightly associated with the
stem–loop part of the mature crRNA (30).
Our previous study reported the presence of promiscuous
ssRNA cleavage activity in SmuCas5c (41). Nonspecific
nuclease activity of this enzyme was further tested against the
repeat RNAs of the two UA19 CRISPR loci (both sense and
antisense strand sequences), an R1c RNA with two additional
nucleotides at the 50-end (R1c+), and a scrambled RNA (RC)
using relaxed reaction conditions (with high protein levels and
extended incubation times). As shown in Fig. S6, SmuCas5c
cleaved all RNA substrates with no specific pattern with
varying size of dominant products. We also tested the Smu-
Cas5c mutant proteins for nonspecific cleavage activity against
several RNA substrates (Fig. S6). Interestingly, while the active
site residues Lys120 and His121 were still important for pro-
miscuous RNA cleavage, alanine replacement of the third triad
residue, Tyr50, had no negative effect on this activity (even
improving the activity compared with the wildtype protein).
Furthermore, mutations in other residues located in the active













































Figure 8. Active site and mutational studies of SmuCas5c. A, close-up view of the SmuCas5c active site (indicated by the red rectangle in panel A)
showing the active site residues selected for mutagenesis. The protein ribbon diagram is colored gray, whereas the active site residues mutated in this study
are shown as sticks with green carbons and labeled. S1, S2, S3, and S4 are sulphate molecules bound to the protein. B, RNase activity of purified wildtype
and mutant proteins against R2 RNA. 50-[32P]-labeled R2 RNA was incubated with SmuCas5c proteins (214 nM) for 20 min at 37 C. These assays were
performed in triplicate with a representative gel presented in this figure alongside a DNA marker.
Structure and activity of the Cas5c ribonuclease SMU1763significant reduction or abolished RNA cleavage suggesting
that these residues contribute to substrate binding.
Promiscuous RNA cleavage activity has also been demon-
strated in purified BhaCas5c and twoCas6 enzymes (Cas6-1 and
Cas6-2a) from Synechocystis sp. PCC 6803 (36, 54). Since both
Cas6 proteins were highly specific for cognate crRNA tran-
scripts in vivo, it has been proposed that the in vivo cleavage of
crRNAs might involve additional Cas protein(s) (54). Further-
more, our experiments with SmuCas5c suggest that promiscu-
ous RNA cleavage by purified Cas5c and Cas6 proteins in vitro
can be observed under relaxed reaction conditions (using high
concentrations of substrate and enzymes).Effect of SmuCas5c deletion on the growth and stress
tolerance of S. mutans cells
Recently, Serbanescu et al. (41) demonstrated that the
deletion of the S. mutans CRISPR2 locus (which also includes
the SmuCas5c gene) results in a higher sensitivity to heat
shock. To determine if SmuCas5c is essential for S. mutansgrowth and stress tolerance, we constructed a SmuCas5c
deletion strain and compared its growth with the wildtype
(UA159) strain. Growth experiments using THYE (rich) me-
dium revealed no apparent growth defects in the SmuCas5c
deletion strain under normal growth conditions (pH 7.0 and
37 C) as well as in the presence of different stressors, such as
low pH (5.5), elevated temperature (50 C), extracellular
(0.003% H2O2) and intracellular (25 mM paraquat) oxidative
stress, cell membrane stress (0.004% SDS), NaCl (0.4 M), and
ethanol (2%) (Fig. S7). These results suggest that there appears
to be no direct role for SmuCas5c in growth and stress
tolerance in S. mutans, and the increased sensitivity of the
S. mutans CRISPR2 deletion mutant is related to the loss of
this CRISPR locus, rather than Cas5c.Conclusions
In the CRISPR–Cas system, Cas5c proteins represent a
multifunctional component, which is involved in crRNA
maturation, cascade complex assembly, and CRISPRJ. Biol. Chem. (2021) 297(5) 101251 11
Structure and activity of the Cas5c ribonuclease SMU1763interference (22, 49). A unique feature of Cas5c proteins is a
combination of metal-independent endoribonuclease activity
involved in crRNA maturation (as in Cas6 proteins) and ability
to bind the crRNA 50-handle and assemble with other Cas
proteins forming an integral part of cascade (like noncatalytic
Cas5 proteins) (32, 35, 49). Cas5c and Cas6 are structurally
similar proteins with metal-independent RNase activity
generating RNA products with 50-OH and 20,30-cyclic phos-
phates (23, 24, 29, 33). Furthermore, these enzymes use a
similar catalytic mechanism and catalytic residues to cleave
pre-crRNA substrates at the base of the stem–loop structure
suggesting a similar mode of crRNA binding (22). However,
interactions with the stem–loop structure and upstream nu-
cleotides appear to be critical for Cas6 activity, whereas Cas5C
proteins seem to recognize the cut site and downstream nu-
cleotides of crRNA (50-handle) (22, 32). Accordingly, Cas5c
and Cas6 proteins were found to be located at opposite ends of
elongated seahorse-shaped cascade complexes with Cas5c
bound near the 50-crRNA handle at the tail of the D. vulgaris
cascade (like noncatalytic Cas5 proteins in type I-E systems),
whereas Cas6 is positioned at the 30-end of the crRNA at the
head of the E. coli cascade (30, 42).
Exquisite binding specificity and affinity of Cas5c and Cas6
proteins are based on extensive contacts made by these pro-
teins with their substrate and product crRNAs, which position
the scissile phosphate in the enzyme active site for cleavage
(22). The crystal structure of SmuCas5c with bound sulfate
molecules implies that S1 and S2 molecules are bound at the
crRNA 50-handle binding site, whereas S3 might indicate the
binding site for the crRNA stem–loop part (Fig. 8A). Site-
directed mutagenesis of SmuCas5c suggested that Tyr50,
Lys120, and His121 represent the catalytic triad of this
enzyme, whereas crRNA binding presumably involves Lys26,
Arg31, Gln43, His51, Lys52, and Arg142 (crRNA 50-handle)
and Tyr179 (crRNA 30-stem loop) (Fig. 8A). Similar catalytic
triads are also present in other Cas5c proteins (Fig. S1), but
they are absent in noncatalytic Cas5 proteins. SmuCas5c
preferentially recognizes and cleaves pre-crRNAs in a
sequence-specific and structure-specific manner, which relies
on base-specific contacts between the nucleotides around the
cleavage site and substrate-binding site residues located on α1,
β2, α3, and connecting loops. Mutational analysis of RNA
substrate nucleotides around the cleavage site demonstrated a
higher tolerance of SmuCas5c (compared with BhaCas5c) to
nucleotide substitutions both upstream and downstream of the
cleavage site (Fig. 7). Thus, our work suggests that there is an
even greater biochemical diversity within the Cas5c family
than it was anticipated before.
Cas5c proteins act as a multifunctional component of small
type I-C cascade complexes, which represent a promising
CRISPR–Cas tool for genome manipulations (35). Type I
systems are the most widespread CRISPR–Cas systems in
nature (11), which enable the use of endogenous cascade–Cas3
complexes for genetic engineering via self-targeting (55–58).
Furthermore, type I systems have been optimized for heter-
ologous genome editing in bacteria as well as for DNA
cleavage and transcriptional modulation in human cells and12 J. Biol. Chem. (2021) 297(5) 101251plants (59–63). Repurposing the naturally streamlined and
minimal type I-C CRISPR system for programmable genetic
manipulations will create a powerful tool both for basic
research and for a wide range of applications in genome en-
gineering including the targeted removal of large genomic
regions and genome minimization.
Experimental procedures
Protein expression, purification, and mutagenesis
Gene cloning and affinity protein purification as well as site-
directed mutagenesis of the 6His-tagged SmuCas5c from
S. mutans UA159 (SMU_1763c; UniProt ID: Q8DSL7) and
BhaCas5c from B. halodurans (UniProt ID: Q9KFY3) were
performed as described previously (64). The oligomeric state
of purified proteins (2.5 mg/ml, 5 mg per load) was analyzed
using size-exclusion chromatography in 50 mM Hepes–
potassium buffer (pH 7.5) containing 150 mM NaCl on a
Superdex 200 HiLoad 16/60 GL or Superdex 200 10/300 GL
column (Amersham Biosciences) as reported previously (65).
Molecular weight standards used were from Bio-Rad (catalog
no.: 1511901): thyroglobulin (670 kDa), γ-globulin (158 kDa),
ovalbumin (44 kDa), myoglobin (17 kDa), and vitamin B12
(1.4 kDa). The molecular weight was calculated using the
Unicorn 4.12 software (Amersham Biosciences).
Preparation of nucleic acid substrates
The RNA oligonucleotides used in this work (Table S2)
were purchased from IDT. The oligonucleotides were
[32P]-labeled at the 50-end using the T4 PNK (BioLabs) and
purified as described previously (66). The synthetic dsDNA
substrates were prepared by annealing oligonucleotides DNA1
and DNA2 as described in Table S2.
Nuclease and DNA-binding assays
The reaction mixture for RNase assays with Cas5c proteins
contained 50 mM Hepes–potassium (pH 7.0), 50 mM KCl,
1 mM DTT, 0.1 μM 50-[32P]-labeled RNA substrate, and
indicated amounts of Cas5c proteins (higher protein amounts
were used in experiments for product analysis, e.g., Fig. 6). The
solutions were incubated at 37 C and analyzed by non-
denaturing PAGE and autoradiography as previously described
(66). Reactions with purified BhaCas5c were carried out using
the same reaction mixture incubated at 20 C. The synthetic
dsDNA substrates were prepared by annealing oligonucleo-
tides DNA1 and DNA2 by incubating at 90 C for 4 min fol-
lowed by 10 min at 37 C in a thermocycler and a slow
cooldown to room temperature on benchtop (Table S2). DNA
cleavage assays contained 641 nM SmuCas5c in 50 mM
Hepes–potassium (pH 7.0), 50 mM KCl, 2 mM metal ion, and
5 nM of the M13mp18 ssDNA or 20 nM pUC19 dsDNA.
Reactions were incubated for 30 min at 37 C and analyzed by
agarose gel electrophoresis and SYBR Green staining as pre-
viously described (66). DNA-binding assays with 107 nM to
2 μM SmuCas5c contained 50 mM Tris–HCl (pH 7.0), 50 mM
KCl, 2 mM metal ion, and 0.1 μM 50-[32P]-labeled substrate.
Reactions were incubated for 1 h at 37 C and analyzed by
Structure and activity of the Cas5c ribonuclease SMU1763nondenaturing PAGE and autoradiography as previously
described (66). The reaction mixture for RNase assays with
RNase T1 contained 1× RNA Structure Buffer (Ambion), 1 μg
of yeast RNA, 0.1 μM 50-[32P]-labeled substrate, and 0.01 to
0.2 U of RNase T1 (Ambion). The solutions were incubated at
room temperature for 15 min, and reaction products were
analyzed by denaturing PAGE and autoradiography. The
analysis of the ssRNA product ends was carried out using
T4 PNK as previously described (66).
Crystallization and structure determination of SmuCas5c
SmuCas5c was crystallized at room temperature using the
hanging drop vapor diffusion protocol by mixing 1 μl of the
SeMet-substituted protein (10 mg/ml in 10 mM Hepes–
potassium, pH 7.5, and 500 mM NaCl) with 1 μl of the crys-
tallization solution containing 0.1 M Tris–HCl (pH 8.5), 12%
glycerol, 1.5 M ammonium sulphate, 0.02 mg/ml of subtilisin
(temperature of 16 C). The crystals were stabilized with the
crystallization buffer containing 3 M NaCl followed by cry-
oprotection in Paratone-N prior to flash freezing in liquid
nitrogen. A set of single-wavelength diffraction data was
collected near the selenium absorption peak (12.66 keV) at
100 K from one SeMet-labeled SmuCas5c crystal at the 19-ID
beamline of the Structural Biology Center at the Advanced
Photon Source at Argonne National Lab using the program
SBCcollect (67).
The data were integrated, scaled, and merged with the
HKL3000 program suite (68). The heavy atom Se sites were
located using the program SHELXD (69), and they were used
for phasing with the program MLPHARE (70). After density
modification (70), a partial model was built in three cycles of
Arp/Warpmodel building (71). All the aforementioned pro-
grams are integrated within the HKL3000 program suite (68).
The structural model of SmuCas5c was completed after several
iterative cycles of model building using the program COOT
(72) and restrained refinement using the program Refmac (70).
Final refinements including translation/libration/screw
refinement were carried out with the program Phenix.refine
(73). Structural validation was performed using the program
Molprobility (74). Sulphate groups were identified based on
the match of electron densities, anionic groups, and potential
interactions between anions and positively charged side chains.
Data collection and structure refinement statistics for the
SmuCas5c structure are summarized in Table S1. The atomic
coordinates and structure factors of SmuCas5c have been
deposited in the PDB under the accession code 4R0J.
Sequence and structural analyses
Phylogenetic analysis of the Cas5c family was performed
using 1548 Cas5c sequences (InterPro database; IPR010155)
aligned using the MAFFT-online server (version 7) (https://
mafft.cbrc.jp/alignment/server/). The phylogenetic tree of
Cas5c proteins was built the FastTree 2.1.5 algorithm built in
Geneious 8.1.9 with 60% threshold (https://www.geneious.
com/download/previous-versions/). Analysis of potential sec-
ondary structures of the S. mutans crRNAs was performedusing the Mfold web server (http://www.unafold.org) (47).
Surface electrostatic potential of SmuCas5c was calculated
using the PDB2PQR and APBS servers (https://server.
poissonboltzmann.org/) (75, 76), whereas surface conserva-
tion was determined based on the alignment of 1548 Cas5c
sequences using ConSurf (https://consurf.tau.ac.il) (46).
S. mutans growth and stress resistance assays
The preparation of the S. mutans Cas5c deletion strain
(ΔCas5c) was described previously (Table S3) (41). Growth
analysis of S. mutans wildtype and mutant cells was performed
using a microplate reader (Bioscreen C Labsystems) equipped
with BioLink software (Labsystems) programmed to monitor
an absorbance at 600 nm at 37 C every 20 min for 24 h, with
moderate shaking every 10 min (41). Overnight cultures were
diluted (20×) in fresh THYE (rich) medium (Todd–Hewitt
broth supplemented with 0.3% yeast extract) and grown to an
absorbance of approximately 0.4. About 20 μl at 600 nm of
midlogarithmic phase cells for the mutant and wildtype strains
were inoculated in triplicate into microtiter plate wells con-
taining 350 μl of THYE. Wells containing uninoculated THYE
were used as controls. To generate growth curve, measure-
ments of an absorbance at 600 nm were plotted against time.
The following stressors affecting growth rates were tested as
described previously (77): acid (pH 5.5), ethanol (5%, v/v),
NaCl (0.4 M), paraquat (25 mM), and H2O2 (0.006%, v/v). For
heat shock resistance assays, overnight cultures grown in
THYE medium were diluted 1:20 using prewarmed THYE, and
two culture aliquots were then grown until midlogarithmic
phase (absorbance at 600 nm = 0.4). One aliquot of each
culture was incubated at 50 C for 60 min, and the other
aliquot was used to assay survival at time 0. Samples were
gently sonicated and serially diluted in PBS, and sensitivity was
quantitatively assessed by plating cells before and after heat
shock incubation. Each dilution was then spotted in triplicate
(20 μl each) onto THYE agar plates and incubated at 37 C for
2 days, and colonies (colony-forming unit [CFU]) were coun-
ted. Heat shock resistance was calculated by dividing the
number of CFUs obtained after incubation at 50 C for 60 min
by the number of CFUs present at time 0 and multiplying the
result by 100.
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